• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • APIGENIN
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CIANIDANOL
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CYANIDIN
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • ELLAGIC ACID
      • EMBELIN
      • ERIODICTYOL
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PHLORIZIN
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ADAPTOGENS
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • ADDICTION AND THE BRAIN
      • ADDICTION & STRESS
      • ADDICTION WITHDRAWAL
      • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
      • ADIPOCYTE DIFFERENTIATION
      • ALLERGIES & CYTOKINES
      • ALDOSTERONE & OBESITY/HYPERTENSION
      • ALZHEIMER’S, DEMENTIA, PARKINSON’S
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADDICTION TREATMENT
      • AMPK
      • ANTI AGING
      • ANTIAGING EFFECTS OF COFFEE
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI ATHEROGENIC
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI CARIOGENIC (Protecting From Tooth Decay)
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI GLYCATIVE
      • ANTI GLYCATION AGENTS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • APOPTOSIS
      • APOPTOSIS IN 3T3-L1
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BDNF
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • BRASSINOSTEROIDS
      • CALORIE RESTRICTION
      • CALORIE RESTRICTION & LIFESPAN EXTENSION
      • CARBAMYLATION
      • CARBONYL SCAVENGER
      • CARBONYL STRESS
      • CARDIOPROTECTIVE AGENTS
      • CARDIAC GLYCOSIDES
      • CATALASE
      • CELL CYCLE ARREST
      • CENTENARIANS
      • CHOLESTEROL EFFLUX
      • COGNITIVE ENHANCEMENT
      • COLD SHOCK PROTEINS
      • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
      • CONDITIONED PLACE PREFERENCE
      • CORTICOTROPIN RELEASING FACTOR
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DIABETES & CANCER
      • DIHYDROTESTOSTERONE (DHT)
      • DNA METHYLATION & AGING
      • DNA REPAIR
      • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
      • ADDICTION & DOPAMINE
      • DRY FASTING AND FLUID RESTRICTION FASTING
      • DYNORPHIN
      • ELLAGITANNINS
      • ENLARGED HEART AND CARDIOMEGALY
      • EPIGENETIC MODIFIERS
      • EPINEPHRINE
      • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
      • EXCITOXICITY & THE BRAIN
      • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
      • EXTENDS LIFESPAN
      • EXTINCTION TRAINING
      • FASTING BRAIN
      • FASTING CANCER
      • FASTING & CANCER
      • FASTING MIMICKING DIET
      • FEAR EXTINCTION
      • FGF21
      • FLAVONES
      • GABA (γ-AMINOBUTYRIC ACID)
      • GALLOTANNINS
      • GLUCONEOGENESIS
      • GLUTAMATE & BRAIN
      • GLYCATION
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HALLMARKS OF AGING
      • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
      • HMGB1
      • HORMESIS
      • HPA AXIS
      • HSP70, THE ANTI-AGING PROTEIN
      • HSP90 INHIBITORS
      • HYPERGLYCEMIA
      • HYPERINSULINEMIA
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • HYPOCRETIN OREXIN
      • IKK
      • IL-6/STAT3
      • IRISIN
      • ISOFLAVONES
      • IMMUNOSENESCENCE
      • INCREASE PROTEIN SYNTHESIS
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INHIBITION OF RENAL GLUCOSE REABSORPTION
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LEYDIG CELL STEROIDOGENESIS
      • LIFESPAN EXTENSION
      • LIPOLYTIC AGENTS
      • LIPID DROPLETS
      • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MEDITERRANEAN DIET
      • MENAQUINONE 4
      • METABOLIC REPROGRAMMING
      • METABOLIC SYNDROME EXTRACT
      • METHIONINE RESTRICTION
      • MITOCHONDRIAL UNCOUPLING
      • MONKEYPOX
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MUSCLE FORCE PRODUCTION
      • MUSCLE ATROPHY (PREVENTING)
      • MYOGENESIS
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTORC2
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL ANTICOAGULANTS
      • NATURAL AROMATASE INHIBITORS
      • NEUROGENESIS (GROWING NEW BRAIN CELLS)
      • NEUROCHEMISTRY OF ADDICTION
      • NEUROPLASTICITY
      • NEUROINFLAMMATION
      • NEUROPROTECTIVE AGENTS
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR AND FEAR
      • NON-OPIOID ANALGESICS (PLANT BASED)
      • NOOTROPICS
      • NORADRENERGIC
      • NOREPINEPHRINE
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OVERNUTRITION
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PERIODONTITIS
      • PHYTOCHEMICALS
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • PROANTHOCYANIDINS
      • PROTEIN CARBONYLATION
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • PUFAS
      • PURGATIVES
      • RAPAMYCIN (MTOR INHIBITION)
      • RECEPTOR “Κ OPIOID”
      • RED WINE
      • RENAL (KIDNEY) PROTECTIVE AGENTS
      • REMINERALIZATION OF TEETH
      • REPAIR OF DNA BREAKS “DOUBLE STRAND”
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SGLT2 INHIBITORS
      • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
      • SHBG
      • SIRT1
      • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
      • SIRT1 & LONGEVITY
      • SMALLPOX
      • SUGAR & AGING
      • STAR PROTEIN
      • STAT3
      • STEM CELL EXHAUSTION
      • STEM CELL REGENERATION
      • STEM CELL THERAPY
      • STIMULATED LIPOLYSYS
      • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
      • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
      • STRESS & AGING
      • STRESS & THE BRAIN
      • TELOMERE SHORTENING & PREMATURE AGING
      • TIME RESTRICTED FEEDING
      • TRAUMATIC BRAIN INJURY (HEALING)
      • TRYPTOPHAN HYDROXYLASE 2
      • VISCERAL ADIPOSITY
    • HOME
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
    February 23, 2021
    TRAUMATIC BRAIN INJURY (HEALING)
    February 23, 2021
    1. A case of advanced cervical esophageal cancer with liver cirrhosis and diabetes mellitus showing a complete response by radiation therapy after the operation for …
    2. A case of an elderly woman with concurrent pancreatic cancer and slowly progressive type 1 diabetes mellitus
    3. A case of central diabetes insipidus caused by metastatic small cell lung cancer
    4. A Case of Central diabetes Insipidus in Patient with Non-small Cell Lung cancer.
    5. A case of diabetes mellitus accompanied by tumor-forming pancreatitis that was difficult to distinguish from pancreatic cancer
    6. A case of effective weekly paclitaxel administration for advanced gastric cancer associated with diabetes mellitus-about the control of blood glucose when …
    7. A Case of Fulminant Type 1 diabetes Mellitus and Diabetic Ketoacidosis Caused by Adjuvant Chemotherapy for Colon cancer
    8. A case of lung cancer with pituitary metastases presented by diabetes insipidus
    9. A case of nephrogenic diabetes insipidus caused by obstructive uropathy due to prostate cancer
    10. A Case of Pituitary Metastasis of Breast cancer Presenting as diabetes Insipidus and Panhypopituitarism.
    11. A case of small cell lung cancer associated with diabetes insipidus and Cushing’s syndrome
    12. A case of type 2 diabetes and metastatic liver cancer exhibiting hypercholesterolemia with abnormal lipoproteins
    13. A Case of Ulcerative Colitis Combined with Follicular Thyroid cancer and Gestational diabetes Mellitus
    14. A case-control study of diabetes mellitus and cancer risk
    15. A Clinical Analysis of Endometrial cancer Accompanied by Hypertension and diabetes Mellitus
    16. A clinical prediction model to assess risk for pancreatic cancer among patients with new-onset diabetes
    17. A clinical prediction model to assess risk for pancreatic cancer among patients with pre-diabetes.
    18. A clinical prediction nomogram to assess risk of colorectal cancer among patients with type 2 diabetes
    19. A cohort study of metformin and colorectal cancer risk among patients with diabetes mellitus
    20. A cohort study of the risk of cancer associated with type 2 diabetes
    21. A COMPARISON OF SPIRITUAL DEVELOPMENT BETWEEN HEALTHY INDIVIDUALS AND PATIENTS SUFFERING FROM cancer AND diabetes
    22. A Comprehensive Analysis of diabetes Self-Management among with Men with Prostate cancer in the United States: Evidence from the National Health and Nutrition …
    23. A Connecting Switch Among Aging, diabetes and Tumor: Avenue Leading to cancer Therapeutics
    24. A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer
    25. A diabetes pay-for-performance program and the competing causes of death among cancer survivors with type 2 diabetes in Taiwan
    26. A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into cancer and Nutrition (EPIC)—Potsdam Study cohort
    27. A genetic link between type 2 diabetes and prostate cancer
    28. A genetic relationship between diabetes and cancer
    29. A high diet quality based on dietary recommendations is not associated with lower incidence of type 2 diabetes in the Malmö Diet and cancer Cohort
    30. A high rate of undiagnosed diabetes in new uterine cancer patients
    31. A historical cohort study on glycemic-control and cancer-risk among patients with diabetes
    32. A Hybrid Machine Learning Scheme to Analyze the Risk Factors of Breast cancer Outcome in Patients with diabetes Mellitus.
    33. A meta-analysis of cohort studies on the association between diabetes and the risk of primary liver cancer
    34. A meta-analysis of diabetes mellitus and the risk of prostate cancer
    35. A molecular rheostat at the interface of cancer and diabetes
    36. A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over time
    37. A new approach for diagnosis of diabetes and prediction of cancer using ANFIS
    38. A new ınsight ınto metformin action: diabetes, prostate cancer, and ıon channels
    39. A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose
    40. A New Role for an Old Drug: Metformin Targets Micro RNA s in Treating diabetes and cancer
    41. A noninvasive method to detect diabetes mellitus and lung cancer using the stacked sparse autoencoder
    42. A novel approach for the diagnosis of diabetes and liver cancer using ANFIS and improved KNN
    43. A NOVEL APPROACH IN COLORECTAL cancer AND diabetes MANAGEMENT: ROLE OF METFORMIN AND RAPAMYCIN
    44. A novel design and analysis of high-sensitivity biosensor based on nano-cavity for detection of blood component, diabetes, cancer and glucose concentration
    45. A novel mechanistic pathway linking diabetes to colorectal cancer: Role of AMPK and mTOR
    46. A novel method for studying the temporal relationship between type 2 diabetes mellitus and cancer using the electronic medical record
    47. A Novel Pathway Linking Oxidative Stress and Inflammation: Prevention of cancer, Sepsis, Asthma, diabetes and Uveitis by Aldose Reductase Inhibition.
    48. A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin
    49. A patient with diabetes and breast cancer in whom virilization was caused by a testosterone-producing mature cystic teratoma containing a brenner tumor
    50. A pilot study evaluating steroid-induced diabetes after antiemetic dexamethasone therapy in chemotherapy-treated cancer patients
    51. A population-based cohort study of all-cause and site-specific cancer incidence among patients with type 1 diabetes mellitus in Taiwan
    52. A Potential Screening Strategy of Pancreatic cancer in New Onset diabetes Patients Using Serum CA19-9 in Combination With Age and BMI: 7
    53. A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 diabetes and Prostate cancer
    54. A Progressive Stack Face-based Network for Detecting diabetes Mellitus and Breast cancer
    55. A prospective study of the associations between treated diabetes and cancer outcomes
    56. A Prospective Study of the Associations Between Treated diabetes Mellitus and cancer Outcomes
    57. A prospective study of type 2 diabetes, metformin use, and risk of breast cancer
    58. A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk
    59. A retrospective study of the impact of diabetes mellitus on survival in patients with lung cancer
    60. A retrospective study of the impact of diabetes mellitus on survival in patients with tung cancer
    61. A retrospective study on the role of diabetes and metformin in colorectal cancer disease progression.
    62. A retrospective study on the role of diabetes and metformin in colorectal cancer disease survival
    63. A retrospective-analysis of the correlation between diabetes mellitus and cancer
    64. A review of cohort studies on the association between history of diabetes mellitus and occurrence of cancer
    65. A review of current knowledge: Role of diabetes, cancer and cytochrome P450
    66. A review of the etiology and biomarkers of pancreatic cancer, with emphasis on the role of diabetes
    67. A Review of the Quality of Life of Hemodialysis, Breast cancer, and Type 2 diabetes Mellitus Patients
    68. A risk stratification schema for predicting diabetes mellitus in cancer survivors.
    69. A simple screening score to predict diabetes in cancer patients: A Korean nationwide population-based cohort study
    70. A Study of the People’s Medicine Scheme in Mumbai and Thane region, India with reference to cancer and diabetes medicines
    71. A study on implementation of national programme for prevention and control of cancer, diabetes, cardiovascular diseases and stroke in Udupi district, Karnataka
    72. A study on utilization of diagnostic and therapeutic services of National Program for Prevention and Control of cancer, diabetes and Cardiovascular Diseases …
    73. A SUCCESSFUL CASE OF GASTRIC cancer WITH diabetes MELLITUS IN 84 YEAR OLD MAN, TOTAL GASTRECTOMIZED WITH TRANSVERSE COLECTOMY
    74. A SURVEY ON IMPROVING THE PERFORMANCE OF cancer AND diabetes DETECTION BY USING NOVEL TECHNIQUE OF MACHINE LEARNING
    75. A Survey on The Roles of Life Style and Its Modification in The Prevention and Management of cancer, diabetes, Blood Pressure and Stroke
    76. A systematic review of cases of diabetes mellitus following immune checkpoint inhibitor therapy for cancer
    77. A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus
    78. A systematic review study on the communication between diabetes and cancer: The serious risk of cancer in diabetic patients
    79. A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors
    80. A ubiquitous membrane fusion protein αSNAP: a potential therapeutic target for cancer, diabetes and neurological disorders?
    81. Aberrant Expression of Sialidase in cancer and diabetes
    82. Aberrant methylation of the Ras-related associated with diabetes gene in human primary esophageal cancer
    83. Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering …
    84. ABO blood group and diabetes mellitus influence the risk for pancreatic cancer in a population from China
    85. ABO blood type, diabetes and risk of gastrointestinal cancer in northern China
    86. ABO blood type, long-standing diabetes, and the risk of pancreatic cancer
    87. Abolish cancer progenitor cells in a mouse model of diabetes associated hepatocellular carcinoma
    88. Aboriginal and Torres Strait islander health: Accuracy of patient self‐report of screening for diabetes, high cholesterol and cervical cancer
    89. Abstract A08: Human preadipocytes promote pancreatic cancer cellular growth in a diabetes-specific manner
    90. Abstract A23: cancer outcomes in the diabetes prevention program outcomes study
    91. Abstract A23: Metformin as a potent antiangiogenic factor: From diabetes to cancer angioprevention
    92. Abstract A27: Association between diabetes pharmacotherapies and bladder cancer: A Medicare epidemiologic study
    93. Abstract A58: Interaction of diabetes and obesity in postmenopausal breast cancer risk among black women
    94. Abstract A76: diabetes and risk of bladder cancer among postmenopausal women in the Iowa Women’s Health Study
    95. Abstract B026: Occurrence of comorbidities among diverse hospice cancer patients with and without diabetes
    96. Abstract B17: Type 2 diabetes, metformin, and ovarian cancer survival: An analysis of tumor registry and electronic medical record data.
    97. Abstract B43: Type 2 diabetes mellitus and colorectal cancer risk in Hispanics: A pilot case-control study
    98. Abstract B45: Obesity, diabetes, other comorbidities and survival in a cohort of women with ovarian cancer
    99. Abstract B94: Relationship of overweight and diabetes with prostate cancer stages in Mexican Americans: A population-based case-control study
    100. Abstract C077: The association between diabetes, plasma fructosamine, and risk of mortality after invasive breast cancer among Hispanic and non-Hispanic white …
    101. Abstract C28: An exploratory study of co-occurrence of breast cancer and diabetes in medically underserved Latinas
    102. Abstract CT198: Efficacy of metfOrmin in PrevenTIng glucocorticoid-induced diabetes in Melanoma, breAst or Lung cancer patients with brain metastases: The phase …
    103. Abstract GS2-09: diabetes risk reduction diet and survival following breast cancer
    104. Abstract LB-18: Statins use prevents ovarian cancer recurrence in women with diabetes mellitus.
    105. Abstract LB-190: Ethnic differences in the relationship between diabetes, adiposity measures and breast cancer-specific mortality
    106. Abstract LB-278: Metformin exposure on survival in localized breast cancer patients with type II diabetes mellitus using electronic health records
    107. Abstract LB-285: Glycemia is positively associated with prostate cancer mortality in white and black men without diabetes when better classifying hyper-and …
    108. Abstract LB-296: Breast cancer metabolism in association with diabetes
    109. Abstract LB-421: diabetes pharmacotherapy: A potential modifier of breast cancer prognosis
    110. Abstract P1-08-05: Type 2 diabetes and survival outcomes among a multi-ethnic cohort of breast cancer patients
    111. Abstract P1-10-02: Type II diabetes and subtype-specific breast cancer risk in medically underserved black and white women
    112. Abstract P2-07-06: Obesity, dyslipidemia, and diabetes as risk factors for trastuzumab-related cardiotoxicity in breast cancer patients
    113. Abstract P2-08-11: High prevalence and incidence of new onset diabetes in metastatic breast cancer
    114. Abstract P2-11-09: Weight Change and Risk of Incident diabetes After Breast cancer
    115. Abstract P3-02-10: The possible association among breast cancer, diabetes mellitus and GLP-1 receptor
    116. Abstract P3-10-32: Breast cancer Patients with Type 2 diabetes Trend To Be Associated with Poor Prognosis
    117. Abstract P344: Association of diabetes and cancer Mortality in American Indians: The Strong Heart Study
    118. Abstract P4-12-07: diabetes Increases the Risk of Breast cancer
    119. Abstract P4-13-08: diabetes, Related Factors and Breast cancer Risk
    120. Abstract P5-12-04: Association of adjuvant endocrine therapy with diabetes among women with postmenopausal breast cancer in the Women’s Health Initiative (WHI)
    121. Abstract P6-09-05: Insulin Resistance, diabetes Mellitus and Breast cancer Risk in Pre-and Postmenopausal Women: Modification Effect by Moderate Physical …
    122. Abstract P6-10-03: The association between type-2 diabetes and risk of mortality after invasive breast cancer among Hispanic and non-Hispanic white women from …
    123. Abstract P6-10-12: Metformin increases survival in hormone receptor-positive, Her2-positive breast cancer patients with diabetes
    124. Abstract PD11-05: diabetes decreases overall survival in women with breast cancer in the southern community cohort study
    125. Abstract PD4-6: Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemias among breast cancer survivors
    126. Abstract PL05-02: Current therapies for diabetes-will they reduce cancer risk?
    127. Abstract PO-159: Mediation of black/white race disparity in triple-negative breast cancer: Effect of type 2 diabetes mellitus
    128. Abstract PO-215: diabetes and the quality of adjuvant therapy in Medicaid-insured women with breast cancer
    129. Abstract PO-237: Colorectal cancer screening in patients with type 2 diabetes mellitus
    130. Abstract PS11-19: Metformin improves the survival in Chinese early invasive breast cancer patients with type 2 diabetes mellitus
    131. Abstract SY02-02: Shared risk factors for diabetes, cardiovascular disease, and cancer in a low-income population
    132. Abstract SY02-04: Risk factors associated with cancer, type 2 diabetes, and cardiovascular disease in the multiethnic cohort: Comparisons across ethnic groups
    133. Abstract# 2111: Effect of IGF gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer
    134. Abstract# 2938: Treatment for diabetes mellitus-2 could prevent pancreatic cancer cell growth
    135. Acanthosis nigricans—decreased extracellular matrix viscosity: cancer, obesity, diabetes, corticosteroids, somatotrophin
    136. Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia
    137. ACS/ADA/AHA issue core recommendations for preventing cancer, cardiovascular disease, and diabetes
    138. Activation of cancer-related and mitogen-activated protein kinase signaling pathways in human mature osteoblasts isolated from patients with type 2 diabetes
    139. Activation of protein kinase p70S6K1 in peripheral blood mononuclear cells of patients with cancer and diabetes
    140. Activities and polymorphisms of MMP-2 and MMP-9, smoking, diabetes and risk of prostate cancer
    141. ADA, ACS Spotlight diabetes–cancer Links
    142. Adapted geometric semantic genetic programming for diabetes and breast cancer classification
    143. Additional risk of diabetes exceeds the increased risk of cancer caused by radiation exposure after the Fukushima disaster
    144. Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes
    145. Additive interaction between the renin-angiotensin system and lipid metabolism for cancer in type 2 diabetes
    146. Addressing different biases in analysing drug use on cancer risk in diabetes in non‐clinical trial settings—what, why and how?
    147. Adenosine monophosphate–activated protein kinase: a central regulator of metabolism with roles in diabetes, cancer, and viral infection
    148. Adherence to a healthy Nordic food index is associated with a lower risk of type-2 diabetes—The Danish diet, cancer and health cohort study
    149. Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010
    150. Adherence to Dietary Indexes by diabetes and Hypertension Status among PLCO cancer Screening Trial Participants
    151. Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment
    152. Adherence to the Danish food-based dietary guidelines and risk of type 2 diabetes: the Danish diet, cancer, and health cohort
    153. Adiponectin as a potential key player in metabolic syndrome: Insights into atherosclerosis, diabetes and cancer
    154. Adiposity and diabetes in breast and prostate cancer
    155. Adiposity-mortality relationships in type 2 diabetes, coronary heart disease, and cancer subgroups in the UK Biobank, and their modification by smoking
    156. Adiposity, history of diabetes, and risk of pancreatic cancer in postmenopausal women
    157. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer
    158. Adopting Nrf2 and NF-κB from cancer: Is there any role of the duo in diabetes?
    159. ADRB2 G–G haplotype associated with breast cancer risk among Hispanic and non-Hispanic white women: interaction with type 2 diabetes and obesity
    160. Adult life after childhood cancer in Scandinavia: diabetes mellitus following treatment for cancer in childhood
    161. Advanced breast cancer in a relatively young man with severe obesity and type 2 diabetes mellitus
    162. Advanced glycation end products in diabetes, cancer and phytochemical therapy
    163. Advances in the studies of the link between diabetes and cancer
    164. Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes–focus on pancreatitis and pancreas cancer
    165. Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes
    166. African American breast and endometrial cancer survivors with type 2 diabetes: Perceived barriers and preferred components for a physical activity program
    167. Age-related differences in the consequences of obesity on cardiovascular disease, type 2 diabetes, osteoarthritis, cancer, physical function, osteoporosis, cognitive …
    168. Age, gender and type 2 diabetes contribute to the risk of gastric cancer: a retrospective single institution analysis
    169. AIDS, diabetes, and lung cancer mortality at the northern Mexican border: 1979-1997
    170. Akt enzyme: new therapeutic target in cancer and diabetes?
    171. Akt2 Redox-regulation in Breast cancer and diabetes
    172. Alarmins in chronic noncommunicable diseases: atherosclerosis, diabetes and cancer
    173. All-cause, cardiovascular, and cancer mortality rates in postmenopausal white, black, Hispanic, and Asian women with and without diabetes in the United States: the …
    174. All‐cause cancer mortality over 15 years in multi‐ethnic Mauritius: The impact of diabetes and intermediate forms of glucose tolerance
    175. Alpha-glucosidase inhibitors and risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis
    176. Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes and cancer
    177. Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: Relevance of the S100A8 N‐terminal peptide (NT‐S100A8)
    178. Alternative splicing of insulin receptor mRNA in cancer and type 2 diabetes mellitus: a review
    179. American diabetes Association 60th Scientific Sessions, 2000: glucose tolerance, diabetes and cancer, glycemic control, monitoring, and related topics
    180. AMP-activated protein kinase: a target for old drugs against diabetes and cancer
    181. AMPK activators as a drug for diabetes, cancer and cardiovascular disease
    182. AMPK-a nutrient and energy sensor with roles in diabetes, cancer and viral infection
    183. AMPK: a target for drugs and natural products with effects on both diabetes and cancer
    184. AMPK: therapeutic target for diabetes and cancer prevention
    185. An analysis of the impact of irrational beliefs and illness representation in predicting distress in cancer and type II diabetes patients
    186. An assessment of the shared allelic architecture between type II diabetes and prostate cancer
    187. An Australian man who stays he developed bladder cancer after using a diabetes drug is taking legal action against the drug’s manufacturer and distributor
    188. An autopsy case of pulmonary tumor thrombotic microangiopathy due to rapidly progressing colon cancer in a patient with type 2 diabetes
    189. An ecological association between the prevalence of diabetes Mellitus and the incidence of colorectal cancer
    190. An elevated HbA1c level is associated with short-term adverse outcomes in patients with gastrointestinal cancer and type 2 diabetes mellitus
    191. An epidemiology study of the relationship between pancreatic cancer and diabetes mellitus
    192. An experimental model of diabetes and cancer in rats
    193. An extended Myc network contributes to glucose homeostasis in cancer and diabetes
    194. An integrated care pathway for cancer patients with diabetes: A proposal from the Italian experience
    195. An integrative hypothesis linking cancer, diabetes and atherosclerosis: the role of mutations and epigenetic changes
    196. An optimization approach to improve classification performance in cancer and diabetes prediction
    197. An uncommon case of T1b breast cancer with diabetic mastopathy in type II diabetes mellitus
    198. An Unusual Case of Emphysematous Cystitis in Non diabetes Metastatic Lung cancer Patient Undergoing Chemotherapy
    199. Anabolic and pro-metabolic functions of CREB-CRTC in skeletal muscle: advantages and obstacles for type 2 diabetes and cancer cachexia
    200. Analysis and prediction of breast cancer and diabetes disease datasets using data mining classification techniques
    201. Analysis of cardiovascular events or diabetes mellitus during androgen deprivation therapy in Korean prostate cancer patients
    202. Analysis of clinical data in breast cancer patients with type 2 diabetes
    203. Analysis of clinical features in colorectal cancer patients with Type 2 diabetes
    204. ANALYSIS OF CLINICAL FEATURES OF COLORECTAL cancer PATIENTS COMBINED TYPE 2 diabetes MELLITUS
    205. Analysis of Drug Use in Clinical Comprehensive Therapy for Advanced Lung cancer Patients with diabetes Mellitus
    206. Analysis of functional genetic polymorphisms in prostate cancer and type 2 diabetes: Mucin 1 and growth hormone receptor
    207. Analysis of gene expression patterns and metabolomics correlated to obesity, diabetes, and outcomes in patients with epithelial ovarian cancer
    208. Analysis of microrna signatures as biomarker to investigate interlink between type 2 diabetes and breast cancer
    209. Analysis of perioperative treatment on 43 cases of gastric cancer complicated with diabetes mellitus [J]
    210. Analysis of Serum Growth Differentiation Factor-15 in Progression of Breast cancer in Type II diabetes Mellitus Patients
    211. Analysis of the association of diabetes mellitus with cancer using autopsy records
    212. Analysis of the changes of blood glucose after radiotherapy in pancreatic cancer patients associated with diabetes mellitus and their related factors
    213. Analysis of the efficacy of surgical treatment for 80 elderly laryngeal cancer patients with type 2 diabetes
    214. Analysis on 57 cases of saving anus surgery for rectal cancer patients incorporated diabetes
    215. Analyzing Targeted Nucleosome Position and Occupancy in cancer, Obesity, and diabetes
    216. Androgen deprivation therapy and risk for diabetes and cardiovascular disease in prostate cancer survivors
    217. Androgen Deprivation Therapy in Patients with Advanced Prostate cancer and Type 2 diabetes Impairs Glucose and Lipid Metabolism: 64
    218. Androgen deprivation therapy increases the risk of diabetes and non-cancer mortality in prostate cancer patients: a meta-analysis
    219. Androgen deprivation therapy, diabetes and poor physical performance status increase fracture risk in Chinese men treated for prostate cancer
    220. Androgen receptor overexpression in prostate cancer in type 2 diabetes
    221. Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer
    222. Androgens, diabetes and prostate cancer
    223. Angiogenesis and inflammation at the crossroads between diabetes and cancer: PS226
    224. Angiopoietin-like protein 2 is a useful biomarker for pancreatic cancer that is associated with type 2 diabetes mellitus and inflammation
    225. Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus: a nationwide case-control study
    226. Animal product consumption and mortality because of all causes combined, coronary heart disease, stroke, diabetes, and cancer in Seventh-day Adventists
    227. Annual fasting plasma glucose variation increases risk of cancer incidence and mortality in patients with type 2 diabetes: the Taichung diabetes Study
    228. Annual glycemic variations and risk of cancer among Chinese patients with type 2 diabetes mellitus: A population-based cohort study in Shanghai
    229. Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis
    230. Anti-Diabetic Medications and Risk of Pancreatic cancer in Patients With diabetes Mellitus: A Systematic Review and Meta-Analysis
    231. Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes
    232. Anti-diabetic medications do not influence risk of lung cancer in patients with diabetes mellitus: a systematic review and meta-analysis
    233. Anti-diabetic treatment and cancer occurrence among patients with type II diabetes mellitus
    234. Antidiabetic medication, statins and the risk and prognosis of non-endometrioid endometrial cancer in women with type 2 diabetes
    235. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes
    236. Antidiabetic medications and mortality risk in individuals with pancreatic cancer–related diabetes and postpancreatitis diabetes: a nationwide cohort study
    237. Antidiabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis
    238. Antidiabetic medications use and cancer risk in type 2 diabetes
    239. Antioxidant genes, diabetes and dietary antioxidants in association with risk of pancreatic cancer
    240. Application of microbiological and immunological enteral nutrition in patients with gastrointestinal cancer complicated with diabetes mellitus
    241. Applications of metabolomics for understanding the action of peroxisome proliferator-activated receptors (PPARs) in diabetes, obesity and cancer
    242. Applications of nanotechnology in drug delivery systems for the treatment of cancer and diabetes
    243. Approaches to gene therapy of complex multigenic diseases: cancer as a model and implications for cardiovascular disease and diabetes
    244. ARE diabetes MELLITUS AND CHROMOSOME 17Q12 GENETIC VARIANTS ASSOCIATED WITH PROSTATE cancer AGGRESSIVENESS?
    245. Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
    246. Are the Different diabetes Subgroups Correlated With All-Cause, cancer-Related, and Cardiovascular-Related Mortality?
    247. Are We doing a Better Job of Understanding Co-morbidity Conditions in Health Care (cancer, Tuberculosis, Hypertension, diabetes, etc.?
    248. Aspects épidémiologiques de l’association diabète et cancer: Epidemiological features of the diabetes–cancer association
    249. Assessing bladder cancer risk in type 2 diabetes clinical trials: the dapagliflozin drug development program as a ‘case study’
    250. Assessing the relationship between institutional cancer and diabetes mortality rates using National Death Index data
    251. Assessment of Blood Donation Safety by People Diagnosed with diabetes, Hypertension, Malaria and cancer
    252. Assessment of classification algorithms in the diagnosis of diabetes and breast cancer
    253. ASSESSMENT OF diabetes MELLITUS AS A MADHUMEHA AND cancer RISK–A REVIEW
    254. Assessment of implementation of the national programme for the prevention and control of cancer, diabetes, cardiovascular diseases, and stroke at …
    255. Assessment of quality of life in patients with cancer and diabetes 2 in Northern Greece
    256. Association between androgen-deprivation therapy and incidence of diabetes among males with prostate cancer
    257. Association between body mass index and obesity-related cancer risk in men and women with type 2 diabetes in primary care in the Netherlands: a cohort …
    258. Association Between Breast cancer and diabetes
    259. Association between cancer antigen 19‐9 and diabetes risk: A prospective and Mendelian randomization study
    260. Association between cancer prevalence and use of thiazolidinediones: results from the Vermont diabetes Information System
    261. Association between consumption of dairy products and incident type 2 diabetes—insights from the European Prospective Investigation into cancer study
    262. Association between diabetes and cancer in Indian and US Populations using Longitudinal Study Design
    263. Association between diabetes and colorectal cancer risk in a homogeneous canadian population
    264. Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population
    265. Association between diabetes and oncological outcomes in patients undergoing neoadjuvant chemo-radiotherapy for rectal cancer
    266. Association between diabetes mellitus and adverse characteristics of breast cancer at presentation
    267. Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature
    268. Association between diabetes mellitus and kidney cancer
    269. Association between diabetes mellitus and lung cancer: meta‐analysis
    270. Association between diabetes mellitus and oncological outcomes in bladder cancer patients undergoing radical cystectomy
    271. Association between diabetes mellitus and subsequent ovarian cancer in women: A systematic review and meta-analysis of cohort studies
    272. Association between diabetes or antidiabetic therapy and lung cancer: A meta‐analysis
    273. Association between diabetes, diabetes treatment and risk of developing endometrial cancer
    274. Association between diagnosed diabetes and self-reported cancer among US adults: findings from the 2009 Behavioral Risk Factor Surveillance System
    275. Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
    276. Association between exposure to desalinated sea water and ischemic heart disease, diabetes mellitus and colorectal cancer; A population-based study in Israel
    277. Association between gestational diabetes mellitus and subsequent risk of cancer: a systematic review of epidemiological studies
    278. Association between glucose‐lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancy
    279. Association between metabolic syndrome, diabetes mellitus and prostate cancer risk
    280. Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a systematic review
    281. Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies
    282. Association between metformin use and mortality after cervical cancer in older women with diabetes
    283. Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population …
    284. Association between pancreatic cancer and metformin use in patients with type 2 diabetes
    285. Association between postprandial hyperglycemia at clinic visits and all-cause and cancer mortality in patients with type 2 diabetes: a long-term historical cohort study …
    286. Association between socioeconomic status and mortality, cardiovascular disease, and cancer in patients with type 2 diabetes
    287. Association Between Statins and cancer Incidence in diabetes: a Cohort Study of Japanese Patients with Type 2 diabetes
    288. Association between the TCF7L2 polymorphism and colorectal cancer does not differ by diabetes and obesity statuses
    289. Association between type 2 diabetes and cancer incidence in China: data in hospitalized patients from 2006 to 2013
    290. Association between type 2 diabetes and cancer incidence in Taiwan: data from a prospective community-based cohort study
    291. Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium
    292. Association between type 2 diabetes mellitus (T2DM), diabetic therapies and clinical outcomes in patients (pts) with metastatic colorectal cancer (mCRC).
    293. Association between type 2 diabetes mellitus risk factors with breast cancer in Mexican women
    294. Association between type 2 diabetes, curative treatment and survival in men with intermediate‐and high‐risk localized prostate cancer
    295. Association between type II diabetes and colon cancer among Japanese with reference to changes in food intake
    296. Association between uric acid, cancer incidence and mortality in patients with type 2 diabetes: Shanghai diabetes registry study
    297. Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective …
    298. Association of Adipose Tissue Distribution With Type 2 diabetes in Breast cancer Patients
    299. ASSOCIATION OF ANGIOTENSIN-RECEPTOR BLOCKERS WITH cancer RISK IN PATIENTS WITH TYPE 2 diabetes MELLITUS
    300. Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes
    301. Association of arterial hypertension, diabetes mellitus and inflammation with cancer incidence and mortality
    302. Association of breast cancer and diabetes mellitus in Korean postmenopausal women
    303. Association of Comorbid diabetes With Clinical Outcomes and Healthcare Utilization in Colorectal cancer Survivors.
    304. Association of Delta-6-Desaturase expression with aggressiveness of cancer, diabetes mellitus, and multiple sclerosis: a narrative review
    305. Association of diabetes and cancer mortality in American Indians: the Strong Heart Study
    306. Association of diabetes and cancer-diagnoses in primary care practices in Germany.
    307. Association of diabetes and diabetes treatment with incidence of breast cancer
    308. Association of diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast cancer Treatment for Breast cancer
    309. Association of diabetes and perineural invasion in pancreatic cancer
    310. Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer
    311. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non‐muscle‐invasive bladder cancer
    312. Association of diabetes mellitus with biological behaviors of colorectal cancer
    313. Association of diabetes mellitus with increased mortality in patients receiving curative surgery for colon cancer.
    314. Association of diabetes mellitus with prostate cancer grade and prostate-specific antigen in Chinese biopsy population
    315. Association of diabetes mellitus with prostate cancer: nested case–control study (Prostate testing for cancer and treatment study)
    316. Association of diabetes mellitus with thyroid cancer risk: A meta-analysis of cohort studies
    317. Association of diabetes Status With Survival After Immune Checkpoint Inhibitor Treatment for Advanced Lung cancer: a Retrospective Study in Japan
    318. Association of diabetes Susceptibility Gene Calpain-10 with Pancreatic cancer Among Smokers
    319. Association of diabetes with colorectal cancer treatment and outcomes.
    320. Association of diabetes with colorectal cancer treatment and outcomes.
    321. Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study
    322. Association of diabetes with oral cancer-an enigmatic correlation
    323. Association of diabetes with perineural invasion and overall survival in surgically resected patients with pancreatic cancer.
    324. Association of diabetes with prostate cancer risk in the multiethnic cohort
    325. Association of diabetes with survival among cohorts of Indigenous and non-Indigenous Australians with cancer
    326. Association of dipeptidyl peptidase 4 inhibitors with risk of metastases in patients with type 2 diabetes and breast, prostate or digestive system cancer
    327. Association of endometrial hyperplasia and cancer with a history of gestational diabetes
    328. Association of endometrial hyperplasia or cancer with a history of gestational diabetes-results from a population-based study in Washington State, 1987-2013
    329. association of Family history of Type 2 diabetes with Prostate cancer: a national cohort study
    330. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
    331. Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review
    332. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: a systematic review and meta-analysis
    333. Association of metformin with breast cancer incidence and mortality in patients with type II diabetes: a GRADE-assessed systematic review and meta-analysis
    334. Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colon cancer in Patients With Type 2 diabetes
    335. Association of serum anti-gad antibody and hla haplotypes with type 1 diabetes mellitus triggered by nivolumab in patients with non–small cell lung cancer
    336. Association of serum C-peptide concentrations with cancer mortality risk in pre-diabetes or undiagnosed diabetes
    337. Association of serum paraoxonase 1 activities, polymorphisms and oxidative stress in breast cancer patients with type 2 diabetes mellitus
    338. Association of tamoxifen use and increased diabetes among Asian women diagnosed with breast cancer
    339. Association of the consumption of common food groups and beverages with mortality from cancer, ischaemic heart disease and diabetes mellitus in Serbia, 1991 …
    340. Association of the severity of diabetes-related complications with stage of breast cancer at diagnosis among elderly women with pre-existing diabetes
    341. Association of thiazolidinediones with gastric cancer in type 2 diabetes mellitus: a population-based case–control study
    342. Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus
    343. Association of type 2 diabetes genetic variants with breast cancer survival among Chinese women
    344. Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study
    345. Association of type 2 diabetes mellitus and the risk of colorectal cancer: a meta-analysis and systematic review
    346. Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate cancer Cohort Consortium
    347. Association of type 2 diabetes with cancer: A meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people
    348. Association of type 2 diabetes with in-hospital complications among women undergoing breast cancer surgical procedures. A retrospective study using the …
    349. Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data
    350. Associations between diabetes and quality of life among breast cancer survivors
    351. Associations between diabetes medication use and risk of second breast cancer events and mortality
    352. Associations of change in television viewing time with biomarkers of postmenopausal breast cancer risk: the Australian diabetes, Obesity and Lifestyle Study
    353. Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region
    354. Associations of hemoglobin A1c with risk of diabetes-related cancers in the cancer Prevention Study-II Nutrition Cohort (CPS-II NC)
    355. Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry
    356. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer
    357. Associations of Telomere Length and diabetes with Pancreatic cancer
    358. Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women
    359. Asymptomatic acute pancreatitis due to tamoxifen-induced severe hypertriglyceridemia in a patient with diabetes mellitus and breast cancer
    360. At the intersection of diabetes and cancer: the role of angiogenesis and inflammation
    361. Atezolizumab-induced autoimmune diabetes in a patient with metastatic lung cancer
    362. Atrial natriuretic peptide and type 2 diabetes development, evidence of causal association from the prospective Malmö diet and cancer study
    363. Attitude toward death in healthy people and patients with diabetes and cancer
    364. Attitudes, perceptions, and family coping in pediatric cancer and childhood diabetes
    365. Atypical diabetes insipidus in small cell lung cancer: paraneoplastic syndrome or metastatic disease?
    366. Atypical early onset of diabetes, deafness and lung cancer in a male patient with mitochondrial mutations in peripheral mononuclear cells
    367. Author Correction: Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials
    368. Author Correction: Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, diabetes, Breast and Prostate cancer
    369. Authors’ reply to editorial linked to their umbrella review of meta-analyses of observational studies on type 2 diabetes and cancer
    370. Autoimmune diabetes superimposed on type 2 diabetes in a patient initiated on immunotherapy for lung cancer
    371. Automatic Extraction of Useful Information from Food-Health Articles related to diabetes, Cardiovascular Disease and cancer
    372. Award of the Foundation for the State of Kuwait Prize for the Control of cancer, Cardiovascular Diseases and diabetes in the Eastern Mediterranean Region
    373. Bamboo extract in the prevention of diabetes and breast cancer
    374. Behavioral genetics of the depression/cancer correlation: a look at the Ras oncogene family and the ‘cerebral diabetes paradigm’
    375. Benefits of screening for pancreatic cancer in new-onset diabetes mellitus
    376. BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer
    377. Beyond diabetes mellitus: role of metformin in non-muscle invasive bladder cancer
    378. Biguanide therapy for diabetes and cancer & a novel methyltransferase that regulates energy expenditure and adiposity and is elevated in many cancers
    379. Bio-Inspired and Nanotechnology-Enabled Drug Delivery for diabetes and Brain cancer
    380. Bioactive Flavonoid Apigenin and Its Nanoformulations: A Promising Hope for diabetes and cancer
    381. Biochemical mechanisms connecting diabetes and cancer. Effects of methormine
    382. Biogenesis of silver nanoparticles to treat cancer, diabetes, and microbial infections: a mechanistic overview
    383. Biologic evaluation of diabetes and local recurrence in non-small cell lung cancer
    384. Biology of circulating nucleic acids and possible roles in diagnosis and treatment in diabetes and cancer.
    385. Bitter melon as a therapy for diabetes, inflammation, and cancer: a panacea?
    386. Bittergourd (Momordica charantia) scavenges free radicals by enhancing the expression of superoxide dismutase in in vitro models of diabetes and cancer
    387. Blacks more likely to die of cancer and diabetes
    388. Bladder cancer In Patients With Type 2 diabetes Treated With Pioglitazone, A Comparative Study
    389. Blood glucose concentrations and breast cancer risk in women without diabetes: a meta-analysis
    390. BMI and weight: their relation to diabetes, CVD, cancer and allcause mortality
    391. Body fat distribution, diabetes, and prostate cancer in Afro-Caribbean men: the Tobago Prostate cancer Survey
    392. Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into cancer and Nutrition (EPIC)-Potsdam study
    393. Body mass index and cancer risk among Chinese patients with type 2 diabetes mellitus
    394. Body mass index and cancer risk in patients with type 2 diabetes: a dose–response meta-analysis of cohort studies
    395. Body mass index and cancer risk in patients with type 2 diabetes: a dose–response meta-analysis of cohort studies
    396. Body mass index and diabetes are important prognostic signatures for bilateral breast cancer prognosis
    397. Body mass index and obesity-and diabetes-associated genotypes and risk for pancreatic cancer
    398. Body mass index and obesity-related cancer risk in men and women with type 2 diabetes (ZODIAC-56)
    399. Body mass index and the risk of cancer incidence in patients with type 2 diabetes in Japan: Results from the National Center diabetes Database
    400. Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into cancer and Nutrition (EPIC)–Potsdam Study–
    401. Body mass index, diabetes and intrahepatic cholangiocarcinoma risk: the liver cancer pooling project and meta-analysis
    402. Body mass index, diabetes and survival after diagnosis of endometrial cancer: a report from the HUNT-Survey
    403. Body mass index, diabetes, and triple-negative breast cancer prognosis
    404. Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study …
    405. Body mass index, type 2 diabetes, and insulin prescription in adolescents and young adults with cancer
    406. Body mass index, waist circumference, diabetes, and risk of liver cancer for US adults
    407. Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study
    408. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden)
    409. Breast and prostate cancer survivors in a diabetic cohort: results from the Living with diabetes Study
    410. Breast cancer and diabetes mellitus
    411. Breast cancer and diabetes mellitus: Complex interactions
    412. Breast cancer and diabetes.
    413. Breast cancer in women with diabetes mellitus type 2
    414. Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase
    415. Breast cancer increases diabetes risk
    416. Breast cancer patients with diabetes mellitus: Defining the population and assessing outcomes.
    417. Breast cancer Radiotherapy Associated diabetes Mellitus Case Reports
    418. Breast cancer resistance protein and diabetes
    419. Breast cancer with diabetes insipidus
    420. Breast cancer, diabetes mellitus and usefulness of immunonutrition
    421. Breast cancer: Increased Risk of Cardiotoxicity Found with Trastuzumab for Elderly Patients with Heart Disease, diabetes
    422. Breast, cervical and colorectal cancer screening in adults with diabetes: a systematic review and meta-analysis
    423. Brief report: the risk of posttraumatic stress disorder in mothers of children diagnosed with pediatric cancer and type I diabetes
    424. Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation
    425. Burden of cancer associated with type 2 diabetes mellitus in Japan, 2010–2030
    426. Burden of cancer attributable to obesity, type 2 diabetes and associated risk factors
    427. Burden of diabetes and oral cancer in India
    428. Burden of diabetes in cancer inpatients
    429. Burden of Health Disparities in Chronic Illnesses: A Report on Cardiovascular Disease, diabetes, and cancer in La Crosse County
    430. Cadmium exposure and incidence of diabetes mellitus-results from the Malmö Diet and cancer study
    431. Can a diabetes Drug Prevent cancer Death?
    432. Can aspirin reduce the risk of colorectal cancer in people with diabetes? A population‐based cohort study
    433. Can diabetes Change the Intrinsic Subtype Specificity of Breast cancer
    434. Can endogenous hyperinsulinaemia explain the increased risk of cancer development and mortality in type 2 diabetes: evidence from mouse models
    435. Can luteolin be a therapeutic molecule for both colon cancer and diabetes?
    436. Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2
    437. Can pancreatic cancer be detected by adrenomedullin in patients with new-onset diabetes? The PaCANOD cohort study protocol
    438. cancer among patients with diabetes, obesity and abnormal blood lipids: a population-based register study in Sweden
    439. cancer among patients with type 2 diabetes mellitus: a population-based cohort study in northeastern Italy
    440. cancer and cholesterol: understanding the V-shaped association in patients with diabetes
    441. cancer and diabetes
    442. cancer and diabetes
    443. cancer and diabetes
    444. cancer and diabetes mellitus a review of the literature
    445. cancer and diabetes mellitus based on autopsy data
    446. cancer and diabetes‐a follow‐up study of two populationbased cohorts of diabetic patients
    447. cancer and diabetes, an increasing common combination: Improving knowledge among oncology nurses.
    448. cancer and diabetes: are there similarities?
    449. cancer and diabetes: are we ready for prime time?
    450. cancer and diabetes: new links and new challenges
    451. cancer and diabetes: two pathological conditions in which adrenomedullin may be involved
    452. cancer as a metabolic disease and diabetes as a cancer risk?
    453. cancer biology and prevention in diabetes
    454. cancer biology in diabetes
    455. cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment,
    456. cancer detection rates following enrolment in a disease management programme for type 2 diabetes
    457. cancer has overtaken cardiovascular disease as the commonest cause of death in Scottish type 2 diabetes patients: A population‐based study (The Ayrshire diabetes …
    458. cancer in diabetes patients: Basing a wrong conclusion on a wrong or on a correct analyses.
    459. cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies
    460. cancer in south Karnataka and its paradoxical relation to diabetes mellitus
    461. cancer incidence among Finnish people with type 2 diabetes during 1989–2014
    462. cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study
    463. cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study
    464. cancer incidence and mortality in patients with type 2 diabetes treated with human insulin: a cohort study in Shanghai
    465. cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark
    466. cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden
    467. cancer incidence in patients with type 2 diabetes mellitus in Minhang District of Shanghai
    468. cancer incidence in patients with type 2 diabetes mellitus: a population-based cohort study in Shanghai
    469. cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals
    470. cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity.
    471. cancer incidence in type 1 diabetes: A 5-country study of 9,000 cancers in type 1 diabetic individuals Electronic Supplementary Material
    472. cancer incidence in type 2 diabetes patients-first results from a feasibility study of the D2C cohort
    473. cancer morbidity in patients with diabetes mellitus
    474. cancer of the breast, diabetes and pathological glucose tolerance
    475. cancer of the organs of the reproductive system in women with type 2 diabetes. Effects of antidiabetic therapy
    476. cancer of unknown primary is associated with diabetes
    477. cancer Patients with Undiagnosed and Poorly Managed diabetes Mellitus
    478. cancer patients with undiagnosed and poorly managed diabetes mellitus.
    479. cancer prediction for type-2 diabetes using machine learning
    480. cancer prevention with a diabetes pill?
    481. cancer recording in patients with and without type 2 diabetes in the Clinical Practice Research Datalink primary care data and linked hospital admission data …
    482. cancer recording in patients with type 2 diabetes in primary care and hospital admission data: IJPDS (2017) Issue 1, Vol 1: 314 Proceedings of the IPDLN …
    483. cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population‐based cohort study in Sweden
    484. cancer risk among patients with type 2 diabetes mellitus: a population-based prospective study in China
    485. cancer risk among patients with type 2 diabetes: A real‐world study in Shanghai, China
    486. cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation
    487. cancer risk associated with insulin glargine among adult type 2 diabetes patients–a nationwide cohort study
    488. cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis
    489. cancer risk due to type 2 diabetes
    490. cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis
    491. cancer risk in Chinese diabetes patients: a retrospective cohort study based on management data
    492. cancer risk in dialyzed patients with and without diabetes
    493. cancer risk in patients aged 30 years and above with type 2 diabetes receiving antidiabetic monotherapy: a cohort study using metformin as the comparator
    494. cancer risk in patients with diabetes mellitus
    495. cancer risk in patients with type 2 diabetes mellitus and their relatives
    496. cancer Risk in Patients with Type 2 diabetes on Antidiabetic Monotherapy: A Population Based Cohort Study Using National Insurance Health Service Database
    497. cancer risk in people with diabetes: does physical activity and adiposity modify the association? Prospective data from the HUNT Study, Norway
    498. cancer risk in people with type 1 and type 2 diabetes in Australia
    499. cancer risk in type 2 diabetes
    500. cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations
    501. cancer risk is higher in years before and shortly after type 2 diabetes diagnosis, study shows
    502. cancer risks among patients with type 2 diabetes: a 10-year follow-up study of a nationwide population-based cohort in Taiwan
    503. cancer risks from diabetes therapies: evaluating the evidence
    504. cancer risks of anti-hyperglycemic drugs for type 2 diabetes treatment–a clinical appraisal
    505. cancer screening rate in people with diabetes in the Korean population: results from the Korea National Health and Nutrition Examination Survey 2007-2009
    506. cancer Signaling Transcriptome Is Upregulated in Type 2 diabetes Mellitus
    507. cancer specific mortality in insulin-treated type 2 diabetes patients
    508. cancer stem cells generated by alcohol, diabetes, and hepatitis C virus
    509. cancer susceptibility in two rat models of spontaneous diabetes
    510. cancer treatment and cellular stress induced type 2 diabetes mellitus
    511. cancer with diabetes: Prevalence, metabolic control, and survival in a general oncology practice.
    512. cancer with diabetes: prevalence, metabolic control, and survival in an academic oncology practice
    513. cancer-related side effects and diabetes self-management.
    514. cancer-suppressing enzyme adds a link to type 2 diabetes
    515. cancer, cardiovascular disease and diabetes mortality among women with a history of endometrial cancer
    516. cancer, diabetes, and angiotensin blockade: a question of hypohydration.
    517. cancer, Heart Disease, and diabetes in Workers Exposed to 2,3,7,8-Tetrachlorodibenzo- p -dioxin
    518. cancer, heart, and diabetes societies join to publicise uninsured Americans
    519. cancer, obesity, and diabetes: TKIs exert multiple effects on glucose homeostasis
    520. cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
    521. cancer, type 2 diabetes, and ageing: news from flies and worms
    522. Candidate gene polymorphisms for diabetes mellitus, cardiovascular disease and cancer are associated with longevity in Koreans
    523. Capnocytophaga sputigena pneumonia and bacteremia in a patient with diabetes and gastric cancer
    524. Carbohydrate intake and incidence of type 2 diabetes in the European Prospective Investigation into cancer and Nutrition (EPIC)-Potsdam Study
    525. Carbohydrate quantity and quality and risk of type 2 diabetes in the European Prospective Investigation into cancer and Nutrition–Netherlands (EPIC-NL) study
    526. Cardiorespiratory fitness as a predictor of cancer mortality among men with pre-diabetes and diabetes
    527. Cardiovascular comorbidity and ovarian cancer patient survival: history of hypertension, heart disease, and diabetes, evidence from the Ovarian cancer Association …
    528. Cardiovascular disease, cancer, and mortality among people with type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission
    529. Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory
    530. Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity
    531. Cardiovascular, cancer and mortality events after bariatric surgery in people with and without pre‐existing diabetes: A nationwide study
    532. Cardiovascular, diabetes, and cancer strips: evidences, mechanisms, and classifications
    533. Care of esophageal cancer patients with diabetes mellitus–preoperative management and treatment
    534. Care Plan for Resuming the Physical Activity of Patients With Pancreatic cancer and diabetes After Surgery
    535. CARING (cancer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants-a systematic review and a …
    536. Case of small cell lung cancer complicated with diabetes insipidus and Cushing syndrome due to ectopic adrenocorticotropic hormone secretion
    537. Case report of severe Cushing’s syndrome in medullary thyroid cancer complicated by functional diabetes insipidus, aortic dissection, jejunal intussusception …
    538. Case-control study of diabetes-related genetic variants and pancreatic cancer risk in Japan
    539. Case–control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women
    540. Causal Evaluation of Laboratory Markers in Type 2 diabetes on cancer and Vascular Diseases Using Various Mendelian Randomization Tools
    541. Causative relationship between diabetes mellitus and breast cancer in various regions of Saudi Arabia: an overview
    542. Cause of death for those with diabetes and/or cancer provides further support for an important role of vitamin D in reducing risk of many types of disease
    543. Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication
    544. Cause-specific mortality in Scottish patients with colorectal cancer with and without type 2 diabetes (2000–2007)
    545. Causes of death in men with prevalent diabetes and newly diagnosed high-versus favorable-risk prostate cancer
    546. Central diabetes insipidus and Cushing’s syndrome due to ectopic ACTH production by disseminated small cell lung cancer: a case report
    547. Central diabetes insipidus caused by pituitary metastasis of lung cancer
    548. Central diabetes insipidus caused by pituitary metastasis of lung cancer
    549. Central diabetes insipidus caused by pituitary metastasis of lung cancer
    550. Central diabetes Insipidus: An Unusual Initial Presentation of Lung cancer
    551. Ceritinib aggravates glycemic control in insulin-treated patients with diabetes and metastatic ALK-positive lung cancer
    552. Challenges and perspectives in the treatment of diabetes associated breast cancer
    553. Challenges and Rewards of Pharmacotherapy Selection in Patients Newly Diagnosed with Lung cancer and diabetes Mellitus
    554. Challenges in the management of people with diabetes and cancer
    555. Challenges of imaging for cancer in patients with diabetes and obesity
    556. Change in the incidence of diabetes mellitus in oral cancer patients based on a long-term comparative study
    557. Changes in blood glucose of elderly patients with gastric cancer combined with type 2 diabetes mellitus after radical operation and the effect of mediation …
    558. Changes in glucose-lowering drug use before and after cancer diagnosis in patients with diabetes
    559. Changes in intake of dairy product subgroups and risk of type 2 diabetes: modelling specified food substitutions in the Danish Diet, cancer and Health cohort
    560. Changes in medication management after a diagnosis of cancer among medicare beneficiaries with diabetes
    561. Changes on blood glucose of different operation scheme after gastrectomy for gastric cancer in patients complicated with diabetes mellitus
    562. Characteristics and prognosis of breast cancer patients with type-2 diabetes mellitus
    563. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors
    564. Characteristics of the clinical course of breast cancer in patients with diabetes mellitus
    565. Characteristics of treatment of patients with breast cancer and diabetes mellitus
    566. Characterizing hyperglycemia in cancer patients with diabetes in an Emergency Center
    567. Chemical Investigations of diabetes Mellitus, Malaria, and Castrate-Resistant Prostate cancer
    568. Chemokine like receptor-1 (CMKLR-1) receptor: a potential therapeutic target in management of chemerin induced type 2 diabetes mellitus and cancer
    569. Chemotherapy and glycemic control in patients with type 2 diabetes and cancer: a comparative case analysis
    570. Childhood cancer Survivors Have More diabetes
    571. Childhood cancer, type 1 diabetes and other immune diseases: healthcare visits in the year before diagnosis in Taiwan
    572. Chinese herbal products and the reduction of risk of breast cancer among females with type 2 diabetes in Taiwan: A case–control study
    573. Cholesterol drugs improve breast cancer prognosis in women with diabetes mellitus
    574. Christian Religious Coping with HIV, cancer, and diabetes: African American Women and the Church’s Response
    575. Chronic diseases and health care: new trends in diabetes, arthritis, osteoporosis, fibromyalgia, low back pain, cardiovascular disease, and cancer
    576. Chronic Low‐grade Inflammation in Obesity and diabetes associated Colorectal cancer Development.
    577. Chronic pancreatitis, type 3c diabetes, and pancreatic cancer risk
    578. Circulating nucleic acids in plasma and serum: roles in diagnosis and prognosis in diabetes and cancer.
    579. Circulating soluble receptor for advanced glycation end products and other factors in type 2 diabetes patients with colorectal cancer
    580. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
    581. Circulating vascular endothelial growth factor (VEGF) levels in advanced stage cancer patients compared to normal controls and diabetes mellitus patients with critical …
    582. Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients
    583. Classification of cancer for Type 2 diabetes Using Machine Learning Algorithm
    584. Clinical analysis of breast cancer patients with type 2 diabetes mellitus in Xinjiang
    585. Clinical analysis of endometrial cancer patients with obesity, diabetes, and hypertension
    586. Clinical challenges in caring for patients with diabetes and cancer
    587. Clinical characteristics of pancreatic cancer according to the presence of diabetes mellitus
    588. Clinical course of diabetes after gastrectomy according to type of reconstruction in patients with concurrent gastric cancer and type 2 diabetes
    589. Clinical differences between patients with new-onset diabetes and those without it in a cohort of individuals with pancreatic cancer
    590. Clinical effects of postoperative early enteral nutrition for the gastric cancer patients with diabetes [J]
    591. Clinical epidemiological analysis of the relationship between pancreatic cancer and diabetes mellitus: data from a single institution in China
    592. Clinical features and molecular phenotypes of breast cancer in patients with type-2 diabetes mellitus
    593. Clinical improvement of diabetes mellitus type 1 by bD-mannuronic acid (M2000) in a breast cancer patient—as a case report
    594. Clinical outcome of pancreatic cancer patients with diabetes mellitus: is diabetes a poor prognostic factor?
    595. Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes
    596. Clinical pathological characteristics of breast cancer patients with secondary diabetes after systemic therapy: a retrospective multicenter study
    597. Clinical Research on the Relationship between Type 2 diabetes Mellitus and Colorectal cancer
    598. Clinical review 63: diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy
    599. Clinical significance of serum lncRNA cancer susceptibility candidate 2 (CASC2) for chronic renal failure in patients with type 2 diabetes
    600. Clinical significances of superoxide dismutases: changes in aging, diabetes, ischemia, and cancer
    601. Clinical study of cytidine deaminase in serum of cancer thalassemia and diabetes patients
    602. Clinical Translational Research: cancer, diabetes, and Cardiovascular Disease
    603. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study
    604. Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer
    605. Clinicopathologic characteristics and prognostic analysis of luminal B breast cancer patients with diabetes
    606. Clinicopathologic features of breast cancer patients with type 2 diabetes mellitus in southwest of China
    607. Clinicopathological and prognostic features of operable non‐small cell lung cancer patients with diabetes mellitus
    608. Clinicopathological characteristics and prognosis of breast cancer patients with type 2 diabetes mellitus
    609. Clinicopathological characteristics of colorectal cancer complicated with type 2 diabetes mellitus: analysis of clinicopathological data from 3, 202 colorectal cancer …
    610. Clinicopathological characteristics of type 2 diabetes mellitus complicated with colorectal cancer
    611. Clinicopathological features of pancreatic cancer-related diabetes.
    612. Close Relationship between diabetes and cancer
    613. Co-existing prostate cancer and diabetes mellitus: implications for patient outcomes and care
    614. Co-Managing Patients with Type 1 diabetes and cancer
    615. Co-morbilities and survival of patients initially diagnosed with extensive-stage small cell lung cancer: Impact of hypertension, diabetes and chronic hepatitis B …
    616. Co-occurrence of diabetes and breast cancer among women by ethnicity
    617. Co-occurrence of diabetes, myocardial infarction, stroke, and cancer: quantifying age patterns in the Dutch population using health survey data
    618. Codon 72 polymorphisms of p53 are associated with obesity, diabetes, and race in breast cancer
    619. Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer
    620. Cohort profile: the Australian and New Zealand diabetes and cancer collaboration (ANZDCC)
    621. Cohort study of cancer incidence in patients with type 2 diabetes: record linkage of encrypted data from an external cohort with data from the epidemiological cancer …
    622. Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes
    623. Cohort study of pioglitazone and cancer incidence in patients with diabetes
    624. Colon cancer Patients with diabetes Have Increased Risk of Recurrence
    625. Colorectal and prostate cancer risk in diabetes: metformin, an actor behind the scene
    626. Colorectal cancer and diabetes
    627. Colorectal cancer associated with BMI, physical activity, diabetes, and blood glucose.
    628. Colorectal cancer in patients with type 2 diabetes mellitus: A single-center experience
    629. COLORECTAL cancer IN PATIENTS WITH TYPE 2 diabetes MELLITUS: PRELIMINARY RESULTS FROM AN ONGOING CASE-CONTROL STUDY
    630. Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis
    631. Colorectal cancer Risks According to Sex Differences in Patients With Type II diabetes Mellitus: A Korean Nationwide Population-Based Cohort Study
    632. Colorectal cancer screening in North Carolina: associations with diabetes mellitus and demographic and health characteristics
    633. Colorectal cancer, diabetes and survival: epidemiological insights
    634. Colorectal cancer: another complication of diabetes mellitus?
    635. Colorectal cancer: Histopathologic differences in tumor characteristics between patients with and without diabetes
    636. Combination of type 2 diabetes and smoking increases total cancer mortality in Japanese men using competing risk analysis: the Tanno-Sobetsu study
    637. Combined effect of obesity and diabetes on early breast cancer outcome: a prospe